SOPH

SOPHIA GENETICS SA CHF0.05 Common Stock

SOPH·H82027105·US·Common Stock·Healthcare - Health Information Services-13D/G

SOPH (SOPHIA GENETICS SA CHF0.05 Common Stock) is held by 30 institutional investors as of Q1 2026. Largest holders: GENERATION INVESTMENT MANAGEMENT LLP ($33.6M), AKRE CAPITAL MANAGEMENT LLC ($18.4M), BANQUE PICTET & CIE SA ($10.9M). Net institutional sentiment: Mixed.

30
Holders
Avg rating(9 Elite)
$86.8M
Total Value
54% (36)
Fund Consensus
15 buying - 13 selling
SOPHSmart Money Verdict
View all
Held by 30 funds
9 elite
Who's Trading
InsiderXZXu ZhenyuSell $23KJul 13, 2026
InsiderMPMenu PhilippeSell $29KJul 13, 2026
InsiderCJCamblong JurgiSell $48KJul 10, 2026
InsiderCJCamblong JurgiSell $93KJul 7, 2026
InsiderCJCamblong JurgiSell $118KJul 6, 2026
InsiderMRMuken RossSell $51KJul 6, 2026
InsiderXZXu ZhenyuSell $38KJul 6, 2026
InsiderCGCARDOZA GEORGESell $8KJul 6, 2026
ActivistBVBalderton Capital VI, S.L.P.4.9%Feb 11, 2026
ActivistAKRE CAPITAL MANAGEMENT, LLCAKRE CAPITAL MANAGEMENT, LLC5.6%Jun 27, 2025
13F: Insider & Congress:
Fund
Action
Shares
Value
Weight
Est. P&L
Conviction
Unchanged
6.8M$33.6M0.3%-64.47%
0
Unchanged
3.7M$18.4M0.3%+43.36%
0
Unchanged
2.2M$10.9M0.1%-28.92%
0
Increased
1.8M(+322.1%)$9M0.1%+32.97%
44
Increased
1.4M(+0.7%)$7M0.0%-32.52%
27
Increased
444,954(+143.9%)$2.2M0.0%+53.29%
42
New
357,888$1.8M0.0%+37.80%
36
Increased
190,010(+1.2%)$940,5500.0%+74.09%
25
Decreased
149,133(-6.9%)$738,2080.0%+82.85%
0
Increased
92,226(+49.0%)$456,5190.0%+27.05%
33
Decreased
92,146(-0.5%)$456,1220.0%-3.11%
0
Decreased
59,800(-27.9%)$296,0100.0%+27.23%
0
Increased
57,628(+101.1%)$285,2590.0%+46.97%
26
Decreased
31,465(-2.3%)$155,7520.0%+69.61%
0
Decreased
23,180(-51.8%)$114,7410.0%+23.35%
0
New
21,563$106,7370.0%+37.80%
33
Increased
19,381(+3130.2%)$96,0000.0%+38.84%
24
Decreased
13,156(-56.9%)$65,1220.0%+24.22%
0
New
12,549$62,1180.0%+37.80%
29
New
10,198$50,4800.0%+37.80%
31

Showing 1-20 of 36

1 / 2

Other Healthcare stocks held by institutions

Data sourced from four SEC data sources: 13F, Form 4, 13D/13G, and STOCK Act. Not financial advice. Full disclaimer

Analytics tracking helps us improve the product. Essential functions stay on either way. How analytics data is used